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Poly(A)+ RNA isolated from the livers of normal rats and of rats suffering from an acute inflammation 
was translated in a cell-free translation system from rabbit reticulocytes. The translation products were 
immunoprecipitated with specific antisera gainst al-acid glycoprotein, cr2-macroglobulin, transferrin, 
al-proteinase inhibitor and albumin. 15 to 21 h after intramuscular injection of turpentine 73-, 66-, 2.8-, 
and 2-fold increases in translatable mRNAs for al-acid glycoprotein, cu2-macroglobulin, transferrin and 
cul-proteinase inhibitor, respectively, were observed. For albumin a decrease in translatable mRNA to 
about 30% of controls was measured. 
Acute phase protein Ceil-free translation cu2-Macroglobulin al-Acid glycoprotein 
crl-Proteinase inhibitor Transferrin Rat serum albumin 
1. INTRODUCTION 2. MATERIALS AND METHODS 
There is a group of plasma proteins, designated 
as acute phase proteins, which increase during in- 
flammation caused by infections, necrosis, vac- 
cination, burning and neoplastic growth [l-3]. 
The majority of those acute phase proteins studied 
are glycoproteins, which are synthesized in the 
liver and secreted into the blood. 
2.1. Chemicals 
L-[“SJMethionine (> 600 Ci/mmol) was pur- 
chased from the Radiochemical Centre, Amers- 
ham; Protosol was from New England Nuclear 
(Boston MA); Protein A Sepharose CL4B from 
Pharmacia (Preiburg). 
Thus far, in most of the studies on acute phase 
proteins during experimental inflammation [4- 1 l]
plasma concentrations or synthesis rates [l l] have 
been determined. These experiments, however, 
give little information on the mechanisms, which 
underlie the increased synthesis. To learn more 
about the possible mechanisms involved, we have 
measured the levels of translatable mRNA for the 
following acute phase proteins from rat liver: 
al-acid glycoprotein, cul-proteinase inhibitor, 
transferrin, and cy2-macroglobulin during acute 
inflammation. 
2.2. Animals 
Male Wistar rats of 250 g body wt were 
generously supplied by Professor Dr H. Ueberberg 
(Thomae GmbH, Biberach). The animals had free 
access to water and a carbohydrate-rich 20% pro- 
tein diet (Ahromin, Lage). 
2.3. Preparation of specific antisera 
* TO whom correspondence should be addressed 
The preparation of antisera against rat al-acid 
glycoprotein [ 121, transferrin [ 131, al -proteinase 
inhibitor [14] and cuZmacroglobulin [15] has been 
described previously. 
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Fig, 1. Cell-free translation of mRNAs of acute phase proteins and albumin at different imes after turpentine injection. 
Poly(A)” RNA was isolated from the livers of male rats of 250 g body wt at various times after intr~uscul~ injection 
of 1 ml turpentine/animal. Comparable amounts of 3%-radioactivity (15 x lo6 cpm) were used for the immunoprecipi- 
tation of albumin (A), &-acid glycoprotein (B), al-proteinase inhibitor (C), ~2-macroglobulin (I3)and transfer&t (E1 
synthesized in a rabbit reticulocyte system from 8 pg poly(A)* RNA. The immunoprecipitated proteins were subjected 
to sodium dodecyl sulfat~~lya~l~de gel ele~rophores~~ and fluorography as described in section 2. cu2-Macro- 
globulin from rat plasma (182000), ,&galactosidase from Escherichia coli (116000), conalbumin (86000), bovine serum 
albumin (68000), catalase (60000), ov~b~in (43~), yeast alcohol dehydrogenase (37000), porcine elastase (25800), 
soy bean trypsin inhibitor (21 SOO), horse myoglobin (17 800), and lysozyme (14400) were used as && standards. 
Total RNA was extracted with guanidinium I-ICI 
from livers removed from rats at various times 
after intramuscular injection of 4 ml turpen- 
tine/kg body wt as in [16]. Oligo(dT)-cell~ose 
chromatography was used for the isolation of 
poly(A)+ RNA. 
2.5. In vitro tra~~~tio~ of pa&(A)+ RNA and 
immunoprecipitation of a2macroglobuiin 
5-6pg of poly(A)+ RNA were translated in a 
total volume of 0.1 ml in the presence of a 
nuclease-treated rabbit reticulocyte lysate 1171, 
SO&i of [3sS]methionine and 100 units of RNase 
inhibitor purified from human placenta s in 1181. 
The newly-s~th~iz~ proteins were then im- 
munoprecipitated with specific antisera nd pro- 
tein A Sepharose [19]. The immunopr~ipitates 
were solubilized and analyzed by sodium dodecyl 
sulfate-polyac~l~ide slab gel (8~a) electro- 
phoresis [ZO] and fluorography [21]. The radioac- 
tive bands were excised from the gel, solubilized 
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with 90% Protosol in water at 40°C overnight and 
the radioactivity was determined in a liquid scin- 
tillation spectrometer. 
3. RESULTS 
Poly(A)+RNA was isolated from livers of rats at 
different times after turpentine administration and 
translated in a cell-free system from rabbit 
reticulocytes. By use of specific antisera, albumin, 
al-acid glycoprotein, cul-proteinase inhibitor, 
cY2-macroglobulin and transferrin were im- 
munoprecipitated and subjected to electrophoretic 
separation on sodium dodecyl sulfate-polyacryl- 
amide slab gels and fluorography. The levels of 
translatable mRNAs for the acute phase proteins 
al-acid glycoprotein, crl -proteinase inhibitor, 
crZmacroglobulin and transferrin increased 6 h 
after turpentine injection, reached a maximum be- 
tween 15 and 21 h, and declined thereafter (fig.1). 
On the other hand, in the case of albumin a con- 
tinuous decrease in mRNA translatability was 
observed, the rate of the decline being fastened 
during the first 12 h after turpentine adminis- 
tration. 
For quantitation the individual protein bands 
were excised from the gels and their radioactivity 
was determined. As shown in table 1 the levels of 
cul -acid glycoprotein, al-proteinase inhibitor, 
a2-macroglobulin and transferrin mRNAs reached 
maxima 15 h, 18 h, 18 h and 21 h, respectively, 
after turpentine injection. The data clearly show 
that the most dramatic increases in mRNA ac- 
tivities were found for al-acid glycoprotein 
(72.9-fold) and crZmacroglobulin (65.9-fold). 
Only small increases were observed for 
cul-proteinase inhibitor and transferrin mRNA ac- 
tivities. Moreover, these returned relatively soon to 
normal values. 
4. DISCUSSION 
In the experiments presented, it was found that 
the translatable mRNAs for al-acid glycoprotein, 
al-proteinase inhibitor, transferrin and 
cr2-macroglobulin showed increases of very dif- 
ferent extent after turpentine injection. Whereas 
the mRNAs for al-acid glycoprotein and 
auZmacroglobulin increased 73- and 66-fold, 
respectively, the levels of mRNA for cul-proteinase 
inhibitor and transferrin were increased only 2- 
and 3-fold and returned quickly to normal (table 
1). In the case of rat al-acid glycoprotein a 90-fold 
increase in the relative amount of al-acid 
glycoprotein mRNA was found [22] 36 h after the 
onset of inflammation using an al-acid 
Table 1 
Translatability of mRNA for albumin and acute phase proteins (synthesis) experimental inflamation 
Days after 
turpentine 
Albumin al-Acid 
glycoprotein 
al-Proteinase 
inhibitor 
cu2-Macroglobulin Transferrin 
(070) -fold (Q) -fold (“70 x 10 -fold) (“70 x ld -fold) (Vo x 10’ -fold) 
change change change change change 
1 2.66 1 0.03 1 1.91 1 0.07 1 1.27 1 
6 1.94 0.73 0.24 7.1 2.62 1.37 0.81 11.2 1.73 1.36 
12 1.14 0.43 1.55 45.5 2.91 1.52 1.83 25.0 - - 
15 0.98 0.37 2.48 72.9 3.30 1.73 3.24 45.0 2.32 1.83 
18 0.96 0.36 1.82 53.5 3.72 1.95 4.74 65.9 2.50 1.97 
21 0.95 0.36 1.50 44.2 3.19 1.67 2.31 32.1 3.56 2.8 
24 0.86 0.32 1.19 35.0 2.27 1.19 0.93 13.0 1.73 1.36 
40 0.83 0.31 0.85 25.0 2.10 1.10 0.19 2.7 1.23 0.97 
60 0.78 0.29 - - 2.01 1.05 - - 1.13 0.89 
The data are given in percent of total trichloroacetic acid-insoluble radioactivity obtained after cell-free translation of 
poly(A)+ RNA in a reticulocyte lysate. For each immunoprecipitation 15 x lo6 cpm of the total trichloroacetic acid- 
insoluble radioactivity were used 
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glycoprotein-specific mRNA cDNA probe. In our 
experiments the maximum of translatable mRNA 
for al-acid glycoprotein was found already 15 h 
after the injection of turpentine. Using a cDNA 
probe specific for baboon al-acid glycoprotein 
authors in [23] have found increased al-acid 
glycoprotein levels after turpentine administration. 
However, no detailed data were given by these 
authors. 
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Maximum translatability is reached at different 
times for the various proteins after the onset of in- 
flammation. Furthermore, it is remarkable that in 
the case of auZmacroglobulin the mRNA activity 
declines very rapidly. The mRNA for albumin 
shows a rapid initial decrease during the first 15 h 
of inflammation. This finding is in agreement with 
experiments in [24]. 
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It can be concluded from the experiments 
presented in this paper that the increase of al-acid 
glycoprotein, al-proteinase inhibitor, cy2-macro- 
globulin and transferrin observed in plasma after 
turpentine administration is due to increased 
mRNA activities. 
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